Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,913 Cr₹128,186 Cr₹1,433 Cr₹127 Cr₹10,304 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,913 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,913 Cr
Mar2024₹128,186 Cr
Mar2023₹1,433 Cr
Mar2022₹127 Cr
Mar2021₹10,304 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,913 Cr
-98.51
Mar2024 ₹128,186 Cr
8,842.31
Mar2023 ₹1,433 Cr
1,032.80
Mar2022 ₹127 Cr
-98.77
Mar2021 ₹10,304 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹86,353.6 Cr -6.5% 0.6% -5.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

0.6%

-5.4%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses